Skip to main content
. 2017 Jul 25;12(7):e0181734. doi: 10.1371/journal.pone.0181734

Fig 4. DENV DI/DII induces poorly-neutralising, highly-enhancing cross-reactive antibodies.

Fig 4

A) Neutralisation and ADE of all four DENV serotypes, ZIKV, WNV and YFV, with DENV anti-3DI/DII and anti-4DI/DII pooled sera (in all cases, n = 3 for each virus-sera combination). B) FRNT50 titres, as determined in (A), * indicates FRNT50 titres below detection limit of the assay (≥25).